https://www.mana.bio/news/why-does-the-future-of-genetic-medicines-rely-on-lnp-targeting-strategies%3F 2026-04-10 https://www.mana.bio/news/lab-to-startup-podcast%3A- 2026-01-20 https://www.mana.bio/news/mana.bio-unveils-mina%E2%84%A2%2C-the-world%E2%80%99s-first-llm-powered-ai-agent-for-lipid-nanoparticles 2026-01-20 https://www.mana.bio/news/mana.bio-presents-new-data-demonstrating-the-power-of-ai-towards-unlocking-the-potential-of-rna-medicine 2026-01-20 https://www.mana.bio/news/yogev-debbi-discusses-the-future-of-targeted-gene-delivery-in-exclusive-ai-pressroom-interview 2026-01-20 https://www.mana.bio/news/mana.bio-presents-broad-improvements-to-systemic-lipid-nanoparticle-tolerability-by-leveraging-a-novel-ai-driven-safety-model 2026-01-20 https://www.mana.bio/news/sheba-medical-center%2C-arc-%26-mana.bio-announce-partnership-to-revolutionize-rna-delivery-for-cancer-%26-autoimmune-diseases 2026-01-20 https://www.mana.bio/news/mana.bio-named-among-top-20-promising-startups-by-themarker 2026-01-20 https://www.mana.bio/news/mana.bio-joins-nvidia-inception-program%2C-empowering-the-world%E2%80%99s-cutting%E2%80%91edge-startups 2026-01-20 https://www.mana.bio/news/mana.bio-partners-with-ginkgo-bioworks-to-add-delivery-capabilities-as-part-of-its-technology-network-platform-launch 2026-01-20 https://www.mana.bio/news/raising-biotech-podcast%3A-mana.bio-and-programmable-lipid-nanoparticles-with-ceo-yogev-debbi-and-rna-expert-dr-barry-ticho 2026-01-20 https://www.mana.bio/news/israeli-biotech-startup-mana.bio-launches-ai-fueled-programmable-drug-therapy 2023-10-24 https://www.mana.bio/news/exclusive%3A-andreessen-horowitz-backed-startup-is-using-ai-to-design-lipid-nanoparticles-that-go-beyond-the-liver 2026-01-20 https://www.mana.bio/news/mana.bio-closes-oversubscribed-%2419.5m-seed-funding 2023-10-10 https://www.mana.bio/news/the-decade-of-rna-delivery-%E2%80%93-beyond-the-liver 2026-01-20 https://www.mana.bio/news/tech-founders%2C-don%E2%80%99t-be-afraid-of-bio 2026-01-20 https://www.mana.bio/news/mana.bio-integrates-cas-chemical-substance-data-into-its-novel-drug-delivery-ai-platform 2026-01-20